US 10563204
Methods of treating cancer harboring hemizygous loss of TP53
granted A61KA61K31/7088A61K31/7105
Quick answer
US patent 10563204 (Methods of treating cancer harboring hemizygous loss of TP53) held by The Board of Regents of the University of Texas System expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7088, A61K31/7105, A61K45/06, A61K47/6831